Magellan Health Inc  

(Public, NASDAQ:MGLN)   Watch this stock  
Find more results for MGLN
82.50
+0.50 (0.61%)
Real-time:   11:05AM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 81.95 - 82.50
52 week 49.50 - 84.71
Open 82.00
Vol / Avg. 12,398.00/135,508.00
Mkt cap 1.95B
P/E 23.43
Div/yield     -
EPS 3.52
Shares 23.68M
Beta 0.57
Inst. own 97%
Nov 7, 2017
Q3 2017 Magellan Health Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Sep 26, 2017
Magellan Health Inc at Cantor Fitzgerald Global Healthcare Conference - 2:50PM EDT - Add to calendar
Jul 28, 2017
Q2 2017 Magellan Health Inc Earnings Release
Jul 28, 2017
Q2 2017 Magellan Health Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 0.35% 1.57%
Operating margin 1.02% 3.16%
EBITD margin - 5.35%
Return on average assets 0.81% 3.36%
Return on average equity 1.94% 7.19%
Employees 9,700 -
CDP Score - -

Address

4800 N Scottsdale Rd Ste 4400
SCOTTSDALE, AZ 85251-7680
United States - Map
+1-602-5726050 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Magellan Health, Inc. is engaged in the healthcare management business. The Company's segments include Healthcare, Pharmacy Management and Corporate. It is focused on managing special populations, complete pharmacy benefits and other specialty areas of healthcare. Its Healthcare includes its management of behavioral healthcare services and employee assistance program (EAP) services, management of other specialty areas, including diagnostic imaging and musculoskeletal management, and the integrated management of physical, behavioral and pharmaceutical healthcare for special populations, delivered through Magellan Complete Care (MCC). Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists primarily of operational support functions. It provides services to health plans and other managed care organizations (MCOs).

Officers and directors

Barry Michael Smith Executive Chairman of the Board, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Mostafa Kamal Chief Executive Officer of Magellan Rx Management
Age: 36
Bio & Compensation  - Reuters
Sanjeev K. Srivastava Chief Executive Officer - Magellan Healthcare
Age: 49
Bio & Compensation  - Reuters
Caskie R. Lewis-Clapper Chief Human Resource Officer
Age: 52
Bio & Compensation  - Reuters
Daniel N. Gregoire General Counsel, Secretary
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William J. McBride Lead Independent Director
Age: 72
Bio & Compensation  - Reuters
John O. Agwunobi M.D. Independent Director
Age: 52
Bio & Compensation  - Reuters
Eran Broshy Independent Director
Age: 58
Bio & Compensation  - Reuters
Michael S. Diament Independent Director
Age: 48
Bio & Compensation  - Reuters
Perry G. Fine M.D. Independent Director
Age: 64
Bio & Compensation  - Reuters